Socioeconomic and global burden of COVID-19
https://doi.org/10.37489/2588-0519-2021-1-24-34
Abstract
Relevance. Assessment of the burden of disease provides information on the economic consequences of the disease, allows you to assess the social significance, identify areas that require additional clinical and economic research, changes in methodological approaches to the organization of measures for the prevention, early detection and treatment of diseases.
The aim. Assessment of the socioeconomic and global burden of COVID-19 in the Russian Federation (RF).
Materials and methods. Identification and assessment of direct medical, direct non-medical, and indirect costs associated with the development of the coronavirus epidemic. When calculating the socioeconomic burden, the variant of calculations was chosen taking into account the prevalence of the disease. The sources of data on the epidemiology of the disease were data from the Ministry of Health and data from the Government of the RF.
Results. The socioeconomic burden of COVID-19 in 2020 in the RF amounted to about 5.4 trillion rubles (5 % of nominal GDP in 2020) and was largely due to indirect costs due to GDP losses due to a 1.5-month period of self-isolation. The estimated global burden of disease is more than 4 million YLLs globally, of which in the RF 2,486.30 among men and 1,378.22 YLL among women.
Conclusion. The epidemic of the new coronavirus infection has led to colossal economic losses in Russian society. The data presented underscore not only the clinical, but also the economic importance of investing in the development of strategies for the treatment and prevention of new coronavirus infection.
About the Authors
A. S. Kolbin
FSBEI HE «Academician I.P. Pavlov First St. Petersburg State Medical University» of the Ministry of Healthcare of the Russian Federation; FSBEI HE «Saint-Petersburg State University»
Russian Federation
Russian Federation
Kolbin Alexey S. - D. Sci. in Medicine, Professor, Head of the Department of Clinical Pharmacology and Evidence-Based Medicine; professor of the Department of Pharmacology, Medical Faculty
SPIN code: 7966-0845
St. Petersburg
Yu. M. Gomon
Hospital of St. George the Great Martyr; FSBEI HE «Academician I.P. Pavlov First St. Petersburg State Medical University» of the Ministry of Healthcare of the Russian Federation
Russian Federation
Russian Federation
Gomon Yulia M. - PhD in Medical Sciences, Physician-clinical pharmacologist; Associate Professor at the Department of clinical pharmacology and evidence-based medicine
St. Petersburg
Yu. E. Balykina
FSBEI HE «Saint-Petersburg State University»
Russian Federation
Russian Federation
Balykina Yulia E. - PhD in Physico-mathematical Sciences, Department of control processes, faculty of applied mathematics
St. Petersburg
D. Yu. Belousov
LLC «Center for Pharmacoeconomics Research»
Russian Federation
Russian Federation
Belousov Dmitry Yu. - Leading specialist in pharmacoeconomics
SPIN code: 6067-9067
Moscow
V. V. Strizheletskiy
FSBEI HE «Saint-Petersburg State University»; Hospital of St. George the Great Martyr
Russian Federation
Russian Federation
Strizheletskiy Valeriy V. - D. Sci. in Medicine, Professor of surgery Department; Chief Doctor
St. Petersburg
I. G. Ivanov
FSBEI HE «Saint-Petersburg State University»; Hospital of St. George the Great Martyr
Russian Federation
Russian Federation
Ivanov Igor G.- associate professor, Department of propedeutics of intern disease; Deputy of Chief Doctor
St. Petersburg
References
1.
Review
For citations:
Kolbin A.S., Gomon Yu.M., Balykina Yu.E., Belousov D.Yu., Strizheletskiy V.V., Ivanov I.G. Socioeconomic and global burden of COVID-19. Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice. 2021;(1):24-34. (In Russ.) https://doi.org/10.37489/2588-0519-2021-1-24-34
Views:
2381
Email this article 